An interventional study of Bifidobacterium longum subspecies combination and Placebo in Psychological Stress and Mental Health, sponsored by DiproBio (Shanghai) Co., Ltd.. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by DiproBio (Shanghai) Co., Ltd. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Stress, Psychological with a site in China — 9 open to participants now, 11 under way, none of them phase 3. Stress, Psychological · China.
Among the 28 studies in Stress, Psychological with a site in China, this one is the 10th largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2026, is one of 18 with no phase, reaches primary completion later than 9 of the 10 other live ones, and was the 28th registered.
850 studies on the registry are indexed under Stress, Psychological; 139 are open to participants now.
Browse Stress, Psychological studies →9 of the 28 studies in Stress, Psychological with a site in China are open now. Recruiting first, the newest first:
Peking University · Sites in China
Ages 10–18 · Healthy volunteers
Universiti Sains Malaysia · Sites in China
Healthy volunteers
Shengjing Hospital · Sites in China
Ages 18+ · Women only
Second Xiangya Hospital of Central South University · Sites in China
Ages 18+
Xijing Hospital · Sites in China
Ages 18–60
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 75 Stress, Psychological studies recruiting now, 34 (45%) set no upper age limit and 37 (49%) stop at 75 or younger; 14 take children under 18; 49 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 126 is above the median of 84 across 692 interventional studies indexed under Stress, Psychological.
Median enrollment 126 across the 19 interventional studies, 311 across the 9 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 28 have an industry lead sponsor. The 10 most frequent:
DiproBio (Shanghai) Co., Ltd. is the lead sponsor of 5 studies on the registry; 4 are open to participants now.
DiproBio (Shanghai) Co., Ltd. has 1 study filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
1 of the studies in Stress, Psychological with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07940283DiproBio (Shanghai) Co., Ltd.Effects of a Combination of Bifidobacterium Longum Subsp. Longum Strains on Stress and Related Health Outcomes in Young Adult | 2027-06-30 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Stress, Psychological with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a prospective, randomized, double-blind, placebo-controlled, parallel-group clinical trial designed to evaluate the effects of a combination of Bifidobacterium longum subsp. longum strains on stress-related health outcomes in adults. The study plans to enroll 126 adults experiencing stress-related problems, who will be randomly assigned in equal proportions to either the probiotic group or the placebo group and will receive the assigned intervention for 8 weeks. Participants will complete the scheduled study visits and assessments.
The study will systematically evaluate the principal health concerns of young adults experiencing high levels of stress through multiple approaches, including subjective questionnaire assessments, biological sample testing, and gut microbiome analysis. The main assessments will include a comparison of changes in stress status before and after the intervention between the probiotic and placebo groups using validated psychological assessment instruments. The effects of the intervention on sleep quality, quality of life, and related emotional states will also be evaluated. Sleep quality and quality of life will be assessed using validated assessment instruments.
To further investigate the potential biological mechanisms, stool samples will be collected from participants for gut microbiome metagenomic analysis to characterize changes in microbial composition and functional features. Laboratory-based assays will also be used to measure stress-, immune-, and inflammation-related biomarkers. This study is expected to provide preliminary evidence supporting the clinical application of microbiota-targeted interventions based on modulation of the gut-brain axis in populations experiencing high levels of stress.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive Bifidobacterium longum subspecies combination formulation.
Dietary Supplement: Bifidobacterium longum subspecies combination
Participants receive a matching placebo formulation.
Other: Placebo
Participants receive an oral probiotic combination formulation according to the study protocol for the duration of the intervention.
Participants receive a matching placebo formulation according to the same administration schedule as the probiotic intervention.
Depression Anxiety Stress Scales-42 (DASS-42) Stress Subscale Score
Stress levels will be assessed using the Stress subscale of the 42-item Depression Anxiety Stress Scales (DASS-42). The subscale consists of 14 items, each scored from 0 to 3. The total Stress subscale score ranges from 0 to 42, with higher scores indicating greater stress severity. Raw scores will be reported at each assessment time point.
Time frame: Baseline, Week 4, Week 8
Pittsburgh Sleep Quality Index (PSQI) Global Score
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The global score is calculated by summing seven component scores, each ranging from 0 to 3. The total global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. Raw PSQI global scores will be reported at each assessment time point.
Time frame: Baseline, Week 4, Week 8
WHOQOL-BREF Physical Health Domain Score
Quality of life in the physical health domain will be assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire. Domain scores will be transformed to a scale ranging from 0 to 100, with higher scores indicating better quality of life in the corresponding domain. Raw transformed domain scores will be reported at each assessment time point.
Time frame: Baseline, Week 4, Week 8
Relative Abundance of Prespecified Gut Microbial Taxa
The relative abundance of prespecified gut microbial taxa will be assessed using shotgun metagenomic sequencing of fecal samples. Relative abundance will be expressed as a percentage of the total taxonomic abundance assigned to the selected taxa at each assessment time point.
Time frame: Baseline, Week 4, Week 8
Gut stress and immune biomarkers
Time frame: Baseline, Week 4, Week 8
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
Of 472 interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 7 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
DiproBio (Shanghai) Co., Ltd. →